EC halted proceedings against Slovakia in re-export of medicaments

It basically acknowledged medicaments are not common goods, and new rules determining their trading should be found.

Illustrative stock photoIllustrative stock photo (Source: Sme)

The European Commission halted legal proceedings against Slovakia, which introduced legal measures to stop the re-export of medicaments from the country to be sold more expensively abroad, the Pravda daily wrote on May 19.

SkryťTurn off ads
Article continues after video advertisement
SkryťTurn off ads
Article continues after video advertisement

The EC admitted that due to the potential re-exports, Slovak patients could be threatened by a lack of drugs, and thus admitted regulation in trading them. The Health Ministry opines that the EC thus acknowledged that medicaments are not common goods, according to Pravda.

It came to the conclusion that instead of the court trial concerning Slovakia’s failure to fulfil its obligations, it is necessary to seek other ways of handling this complex situation, the Sme daily wrote May 17. Since the international court proceedings have begun, Slovakia has already changed the criticised legislation.

SkryťTurn off ads

In 2013, the country introduced the possibility of banning the re-export of medicaments abroad. Thus, the export was monitored, and in the case of a lack of a medicament, the State Institute for Drug Control (ŠÚKL) prevented the medicament from being exported. However, the EC disliked the legislation and it launched proceedings concerning the violation of legal norms concerning bans on the re-export of medicaments. In March 2015, the EC sent a reprimanding letter to Slovakia.

The EC’s stance

The amendment to the law on medicaments, which became effective as of January 1, 2017, abolished the criticised ban. Since then, only producers and holders of licenses – and not distribution companies – can export drugs financed from public health care.

The EC opines that the parallel import and export of drugs is among legal forms of trade on the unified EU market. In some cases, member states can limit them but the measures have to be justified, adequate and serving legitimate public interest.

SkryťTurn off ads

The EU executive stresses that a lack of adequate and continuous supplies of medicaments for human use to pharmacies is a serious problem, which is ever more and more frequent and that has occurred in recent years in several EU members. It can gravely impact a patient's treatment, and one of the causes for the lack of several drugs for human use can be the parallel trading in medicaments, according to Sme.

Top stories

Janka, a blogger, during the inauguration of the first flight to Athens with Aegean Airlines at the airport in Bratislava on September 14, 2023.

A Czech rail operator connects Prague and Ukraine, Dominika Cibulková endorses Pellegrini, and Bratislava events.


Píšem or pišám?

"Do ľava," (to the left) I yelled, "Nie, do prava" (no, to the right), I gasped. "Dolšie," I screamed. "Nie, nie, horšie..." My Slovak girlfriend collapsed in laughter. Was it something I said?


Matthew J. Reynolds
Czech biochemist Jan Konvalinka.

Jan Konvalinka was expecting a pandemic before Covid-19 came along.


SkryťClose ad